Benzbromarone Inhibits Renal URAT1 and Attenuates Renal Damage in Streptozotocin‐Induced Diabetic Rats, Independent of Its Uricosuric Effects
Journal of Diabetes Research · 2025
DOI: 10.1155/jdr/9934190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Research, 2025. Verfasst von Chuping Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Metabolism Department, Guangzhou Red Cross Hospital Affiliated to Jinan University, Guangzhou, China. Hauptthemen laut MEDLINE: Benzbromarone, Diabetes Mellitus, Experimental, Kidney, Diabetic Nephropathies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Municipal Science and Technology Project.
Abstract (Originalsprache)
Background
Hyperuricemia remains a critical risk factor for diabetic kidney disease (DKD) currently. Recent studies have confirmed that allopurinol, an inhibitor of xanthine oxidase (XO), does not have any beneficial effects on DKD. However, it is still unclear how uricosurics, such as benzbromarone (BZ), affect the progression of DKD.
Methods
STZ‐induced diabetic and control rats were treated with BZ for 8 weeks. Blood samples were collected to measure fasting blood glucose (FBG), serum uric acid (SUA), serum creatinine (SCr), and blood urea nitrogen (BUN). Simultaneously, urinary samples were tested, and the daily urinary amounts of albumin (UAE), uric acid (UUA), creatinine (UCr), urea nitrogen (UUN), were calculated. Gene expressions of XO, urate transporter 1 (URAT1), and glucose transporter 9 (GLUT9) in the kidney, as well as XO, uricase, and GLUT9 in the liver, were detected.
Results
(1) Compared with normal rats, diabetic rats exhibited significant increases in FBG, BUN, UUN, UAE, UUA, while SUA was significantly decreased. BZ significantly decreased UAE and increased SUA over 8 weeks in diabetic rats. (2) Diabetic rats developed noticeable hyaline degeneration, and a slight decrease in mean glomerular area. BZ treatment significantly attenuated tubular damage in diabetic rats without affecting glomerular morphology. (3) In the kidney, gene expression of XO was increased, while URAT1 and GLUT9 were unchanged in diabetic rats. BZ treatment had no effect on GLUT9 and XO gene expression but significantly inhibited URAT1 expression in diabetic rats. (4) In the liver, gene expression of XO, uricase, and GLUT9 did not differ between diabetic and normal rats. BZ treatment significantly inhibited GLUT9 expression but had no effect on XO and uricase expression in diabetic rats Conclusions BZ treatment significantly protects against renal damage in STZ‐induced diabetic rats independent of its uricosuric effects, possibly because of its inhibition of renal URAT1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology and Metabolism Department, Guangzhou Red Cross Hospital Affiliated to Jinan University, Guangzhou, China.
- Institute of Diseases-Oriented Nutrition Research, Guangzhou Red Cross Hospital Affiliated to Jinan University, Guangzhou, China.
ORCID-Profile: Chuping Chen, Ping Zhu, Rongshao Tan, Yan Liu, Jianmin Ran
Förderung
- Guangzhou Municipal Science and Technology Project
Zitieren
APA
Chen, C., Zhu, P., Tan, R., Liu, Y., & Ran, J. (2025). Benzbromarone Inhibits Renal URAT1 and Attenuates Renal Damage in Streptozotocin‐Induced Diabetic Rats, Independent of Its Uricosuric Effects. Journal of Diabetes Research. https://doi.org/10.1155/jdr/9934190
Vancouver
Chen C, Zhu P, Tan R, Liu Y, Ran J. Benzbromarone Inhibits Renal URAT1 and Attenuates Renal Damage in Streptozotocin‐Induced Diabetic Rats, Independent of Its Uricosuric Effects. Journal of Diabetes Research. 2025. doi:10.1155/jdr/9934190
BibTeX
@article{Chen2025,
author = {Chen, Chuping and Zhu, Ping and Tan, Rongshao and Liu, Yan and Ran, Jianmin},
title = {Benzbromarone Inhibits Renal URAT1 and Attenuates Renal Damage in Streptozotocin‐Induced Diabetic Rats, Independent of Its Uricosuric Effects},
journal = {Journal of Diabetes Research},
year = {2025},
doi = {10.1155/jdr/9934190}
}
EUVIMED